PAPI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 34.674
AS - Asia 16.176
EU - Europa 10.058
SA - Sud America 3.208
AF - Africa 286
OC - Oceania 150
Continente sconosciuto - Info sul continente non disponibili 23
Totale 64.575
Nazione #
US - Stati Uniti d'America 34.087
SG - Singapore 6.243
CN - Cina 4.237
BR - Brasile 2.660
HK - Hong Kong 2.117
IT - Italia 1.958
UA - Ucraina 1.852
DE - Germania 1.763
VN - Vietnam 1.098
TR - Turchia 1.085
GB - Regno Unito 1.019
FI - Finlandia 726
NL - Olanda 642
RU - Federazione Russa 596
SE - Svezia 518
ID - Indonesia 448
MX - Messico 308
PL - Polonia 241
IN - India 234
CA - Canada 221
AR - Argentina 210
FR - Francia 199
AU - Australia 133
JP - Giappone 113
ZA - Sudafrica 113
AT - Austria 107
BD - Bangladesh 105
EC - Ecuador 95
ES - Italia 84
IQ - Iraq 72
KR - Corea 60
CO - Colombia 59
BE - Belgio 57
PY - Paraguay 55
LT - Lituania 53
TW - Taiwan 52
PK - Pakistan 50
CZ - Repubblica Ceca 47
VE - Venezuela 39
EG - Egitto 36
KE - Kenya 35
PE - Perù 34
MA - Marocco 33
AE - Emirati Arabi Uniti 27
IE - Irlanda 27
UZ - Uzbekistan 27
CH - Svizzera 26
CL - Cile 24
UY - Uruguay 22
MY - Malesia 20
SA - Arabia Saudita 20
TN - Tunisia 20
IR - Iran 19
TH - Thailandia 19
PT - Portogallo 18
PH - Filippine 17
AL - Albania 16
NZ - Nuova Zelanda 16
DZ - Algeria 15
KZ - Kazakistan 15
EU - Europa 13
GR - Grecia 13
IL - Israele 13
HR - Croazia 12
RO - Romania 12
DO - Repubblica Dominicana 11
NP - Nepal 10
HU - Ungheria 9
LB - Libano 9
RS - Serbia 9
BO - Bolivia 8
JO - Giordania 8
MK - Macedonia 8
VI - Stati Uniti Isole Vergini 8
XK - ???statistics.table.value.countryCode.XK??? 8
AZ - Azerbaigian 7
BG - Bulgaria 7
GE - Georgia 7
JM - Giamaica 7
DK - Danimarca 6
PA - Panama 6
PS - Palestinian Territory 6
TT - Trinidad e Tobago 6
BA - Bosnia-Erzegovina 5
GT - Guatemala 5
HN - Honduras 5
MD - Moldavia 5
MN - Mongolia 5
NG - Nigeria 5
BN - Brunei Darussalam 4
BY - Bielorussia 4
LV - Lettonia 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
BB - Barbados 3
CG - Congo 3
CR - Costa Rica 3
ET - Etiopia 3
KH - Cambogia 3
Totale 64.513
Città #
Fairfield 4.047
Woodbridge 3.629
Singapore 3.078
Ashburn 2.965
Houston 2.631
Hong Kong 2.097
Jacksonville 2.039
Chandler 1.631
Santa Clara 1.557
Seattle 1.511
Wilmington 1.435
Ann Arbor 1.327
Cambridge 1.319
Dallas 1.243
Beijing 1.183
Izmir 700
Nanjing 635
Princeton 564
Munich 518
Los Angeles 474
San Diego 370
Ho Chi Minh City 365
Jakarta 355
Ferrara 344
Boardman 305
New York 292
Milan 273
Washington 234
Mexico City 223
Hanoi 221
Warsaw 218
São Paulo 217
Chicago 207
Nanchang 194
Shanghai 190
Shenyang 170
Tianjin 165
Helsinki 159
Hefei 154
Moscow 141
London 134
Addison 131
Hebei 124
Buffalo 113
Changsha 110
Dearborn 108
Jiaxing 100
Rome 97
Nuremberg 96
Lappeenranta 94
Turku 93
Dong Ket 90
Mountain View 86
Tokyo 85
Rio de Janeiro 84
Falls Church 79
Council Bluffs 78
Redwood City 74
Falkenstein 71
Zhengzhou 70
Brooklyn 66
Norwalk 66
Toronto 64
Frankfurt am Main 61
Boston 59
Denver 58
The Dalles 57
Belo Horizonte 56
Bologna 56
Guangzhou 55
Montreal 54
Vienna 54
Jinan 52
Kunming 50
Bremen 49
Ningbo 48
Chennai 47
Da Nang 47
Brussels 46
Orange 46
San Francisco 46
Atlanta 44
Haiphong 44
Johannesburg 44
Stockholm 44
Verona 44
Curitiba 40
Brasília 38
Phoenix 38
Campinas 37
Columbus 36
San Mateo 36
Manchester 35
Taizhou 33
Amsterdam 32
Ankara 32
Guayaquil 32
Orem 32
Sydney 32
Auburn Hills 31
Totale 43.138
Nome #
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 619
Asthma 445
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 373
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 310
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 307
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 307
Targeting Th2 cells in asthmatic airways 275
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 258
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 253
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial 239
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 229
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD 213
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial 210
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 208
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 207
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 202
Oxygen radical scavengers inhibit clastogenic activity induced by sonication of human serum 200
Emphysema contribution to the progression of chronic obstructive pulmonary disease. 200
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 199
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 195
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 193
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 189
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 189
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 187
Primary pulmonary epithelioid hemangioendothelioma: A rare cause of PET-negative pulmonary nodules 186
Effect of subchronic in vivo exposure to nitrogen dioxide on lung tissue inflammation, airway microvascular leakage, and in vitro bronchial muscle responsiveness in rats 184
Bronchopulmonary inflammation and airway smooth muscle hyperresponsiveness induced by nitrogen dioxide in guinea pigs 183
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 182
Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial 182
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma 182
Malattie polmonari primitive da cause dismetaboliche. 182
Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthma 181
Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS) 178
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 176
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial 175
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 175
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial 173
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 172
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial 172
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy 170
Activation of NF-kappaB transcription factor in asthma death 168
COPD: early diagnosis and treatment to slow disease progression 168
Models of infection and exacerbations in COPD. 167
Diffuse pulmonary meningothelial like nodules simulating metastatic thymoma 167
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 166
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 165
A new combination therapy for asthma: bridging the gap between effectiveness in trials and clinical practice? 165
Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations 165
Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: A randomised controlled trial on the effects of sulphurous thermal water inhalation 164
Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes 164
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 164
Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion 162
Rhinovirus vaccination: the case against 162
Management of bronchial asthma 161
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 161
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease 160
A defective type 1 response to rhinovirus in atopic asthma 159
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells 158
Asthma management 158
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial 158
A serum proteome signature to predict mortality in severe COVID-19 patients 158
Enfisema polmonare: prospettive di terapia 157
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 157
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis 157
INSTEAD: A randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD 157
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 157
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production 156
Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: A pooled analysis 156
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 156
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 155
A valid option for asthma control: Clinical evidence on efficacy and safety of fluticasone propionate/formoterol combination in a single inhaler 155
Tubercolosi extrapolmonare a carico dell’apparato genitale femminile con reazione a catena polimerasica negativa per micobatterio tubercolare. 154
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 154
Mechanisms of rhinovirus-induced asthma 154
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 153
Xanthine oxidase activation by HRV16 infection in respiratory epithelial cells 152
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 152
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 152
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 152
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation 152
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease 151
A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthma 151
Extrafine beclometasone diproprionate/formoterol fumarate: A review of its effects in chronic obstructive pulmonary disease 151
A Novel Insight into Adaptive Immunity in Chronic Obstructive Pulmonary Disease B Cell Activating Factor Belonging to the Tumor Necrosis Factor Family 151
Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. 150
Association between markers of emphysema and more severe chronic obstructive pulmonary disease 150
Apporto esogeno di riducenti e attività del rinovirus HRV16 150
An unusual case of congenital short trachea with very long bronchi mimicking bronchial asthma 150
Dual Bronchodilation Response by Exacerbation History and Eosinophilia in the FLAME Study 150
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study 150
Cost-effectiveness and cost-utility of beclomethasone/formoterol versus fluticasone propionate/salmeterol in patients with moderate to severe asthma. 149
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics 148
COPD exacerbations: definitions and classifications 148
Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS. 148
Severe Pneumonia following intravescical BCG therapy in a patient with bladder cancer. 147
Combination treatment in asthma: Reviewing old and new options 147
Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies 147
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 146
Ectopic thymoma simulating a pericardial cyst: case report 146
Cellule staminali e patologia polmonare dell’adulto 145
Totale 18.393
Categoria #
all - tutte 339.503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 15.635
Totale 355.138


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.526 0 0 0 0 321 681 279 751 170 784 881 659
2021/20225.146 219 452 320 258 197 236 283 293 204 380 461 1.843
2022/20234.213 575 103 145 491 619 645 179 385 531 65 314 161
2023/20242.742 248 267 113 83 137 279 78 136 88 259 348 706
2024/202511.287 303 293 998 331 1.307 813 351 716 1.934 1.653 1.447 1.141
2025/202615.744 2.708 1.677 3.921 4.389 3.049 0 0 0 0 0 0 0
Totale 65.822